PEXIDARTINIB vs PHENPROCOUMON: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PEXIDARTINIB vs PHENPROCOUMON: Safety Overview
| Metric | PEXIDARTINIB | PHENPROCOUMON |
|---|---|---|
| Total FAERS Reports | 970 | 1,387 |
| Deaths Reported | 17 | 140 |
| Death Rate | 1.8% | 10.1% |
| Hospitalizations | 91 | 1,068 |
| Average Patient Age | 44.9 yrs | 71.3 yrs |
| % Female Patients | 63.4% | 45.8% |
| FDA Approval Date | Aug 2, 2019 | Approved Prior to Jan 1, 1982 |
| Manufacturer | Daiichi Sankyo Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Discontinued | Discontinued |